Agile Therapeutics Inc (FRA:0AL)
€ 7.241 0 (0%) Market Cap: 3.30 Mil Enterprise Value: 2.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Agile Therapeutics Inc Virtual Investor/Analyst Day Transcript

Sep 21, 2020 / 03:00PM GMT
Release Date Price: €6178 (+0.85%)
Operator

Good day, and welcome to the Agile Therapeutics Virtual Investor Analyst Day Conference Call. Today's conference is being recorded.

At this time, I'd like to turn the conference over to Mr. Matt Riley. Please go ahead, sir.

Matthew Riley
Agile Therapeutics, Inc. - Head of IR & Corporate Communications

Hello, everyone, and welcome to the Agile Therapeutics Virtual Investor Analyst Day. My name is Matt Riley, Head of Investor Relations and Corporate Communications. And all of us at Agile would like to thank you for taking the time to participate this morning.

We hope all of you are safe and staying healthy during the pandemic, and you'll see -- you'll be joining us today from our home offices and other remote locations.

Before we begin, let me remind you that today's webcast will include forward-looking statements based on current expectations, including statements concerning our outlook for the third and fourth quarters and full year 2020. Management's expectations for our future financial and operational performance, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot